LONDON, July 18, 2023 (GLOBE NEWSWIRE) -- BSF Enterprise PLC ("BSF" or the "Company") (LSE: BSFA), (OTCQB: BSFAF), a company focused on unlocking the next generation of biotechnological solutions using cell-based tissue engineering, today provides a commercial update on the progress of City-Mix TM , the flagship commercial product of its wholly owned subsidiary 3D Bio Tissues (3DBT). 3DBT's City-Mix TM is a patented non-toxic culture media supplement that acts as an effective 'cell booster'. It...